Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study

Journal of Neurology
Giammario RagneddaM Pugliatti

Abstract

Breastfeeding for at least 4 months has been found to be associated with a reduced risk of immune-mediated diseases including multiple sclerosis (MS). Using data from a large multinational case-control study (EnvIMS), the association between MS and breastfeeding was investigated in two distinct populations. A questionnaire (EnvIMS-Q) which included a section on feeding during the first year of life was administered to MS cases and to age and sex frequency-matched controls from Italy and Norway. Logistic regression was used to estimate the odds ratio (ORs) and 95% confidence intervals (95% CIs) as a measure of the association between MS and exposure to prolonged breastfeeding (4 months or more, used as the reference category), vs. no breastfeeding or breastfeeding for less than 4 months (reduced exposure). Education, smoking habits, smoking in mother's pregnancy, and other types of milk used in infant feeding were included as covariates. A total of 547 cases and 1039 controls in Italy, and 737 cases and 1335 controls in Norway were studied. The distribution of prolonged (reference) breastfeeding differed between the Norwegian (65.4%) and the Italian (48.9%) study participants. A significant association between MS and reduced/no ...Continue Reading

References

May 28, 1994·BMJ : British Medical Journal·A PisacaneP Vivo
Sep 20, 2002·The New England Journal of Medicine·Jean-Francois Bach
Jun 19, 2003·The American Journal of Clinical Nutrition·Bo Lönnerdal
Oct 29, 2003·Neurology·Trond RiiseAlberto Ascherio
Jan 14, 2004·Neurology·K L MungerA Ascherio
Nov 9, 2004·The American Journal of Clinical Nutrition·Eyal KlementShimon Reif
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Sep 14, 2007·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·J RosenbauerG Giani
Jan 10, 2009·The Pediatric Infectious Disease Journal·Romina LibsterFernando P Polack
Apr 17, 2010·Journal of Agricultural and Food Chemistry·Angela MarcobalDavid A Mills
Jul 9, 2010·Lancet Neurology·Sreeram V RamagopalanGavin Giovannoni
Aug 9, 2011·Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine·João Guilherme Bezerra AlvesGuilherme Victor Alves
Aug 13, 2011·Nature·UNKNOWN International Multiple Sclerosis Genetics ConsortiumAlastair Compston
Nov 26, 2011·Current Opinion in Immunology·Koji Atarashi, Kenya Honda
Jun 8, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A Marcobal, J L Sonnenburg
Aug 25, 2012·BMB Reports·Kyunghun JeongJaehan Kim
Sep 7, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Silja ConradiBerit Rosche
Sep 15, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Leónides FernándezJuan M Rodríguez
Jan 4, 2013·Acta Neurologica Scandinavica. Supplementum·M PugliattiC Wolfson
Jun 19, 2013·Paediatric and Perinatal Epidemiology·Gillian SantorelliLesley Fairley
Sep 28, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Andreas LossiusTrygve Holmøy
Oct 1, 2013·Nature Genetics·UNKNOWN International Multiple Sclerosis Genetics Consortium (IMSGC)Jacob L McCauley
Jan 15, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Kjetil BjørnevikMaura Pugliatti

❮ Previous
Next ❯

Citations

Jan 5, 2016·Journal of Neurology·Riley BoveD Rintell
May 3, 2016·Therapeutic Advances in Neurological Disorders·Patricia K Coyle
Oct 31, 2017·American Journal of Reproductive Immunology : AJRI·Vânia Vieira BorbaYehuda Shoenfeld
Feb 13, 2018·Scientific Reports·Sebastian EilebrechtTimo Bund
Jul 14, 2017·Neurology·Annette Langer-GouldAnny Xiang
Jan 13, 2017·Multiple Sclerosis International·Raed AlroughaniSaeed Bohlega
Aug 5, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria Pia AmatoGiancarlo Comi
Aug 9, 2019·Annals of Clinical and Translational Neurology·Emmanuelle WaubantAnnette Langer-Gould
Jun 22, 2019·Annals of Neurology·Kassandra L MungerAlberto Ascherio
Jul 31, 2020·Multiple Sclerosis Journal - Experimental, Translational and Clinical·A K HedströmL Alfredsson
Nov 22, 2020·Multiple Sclerosis and Related Disorders·Geraldine G LueticJuan I Rojas
Feb 14, 2021·Multiple Sclerosis and Related Disorders·Nuha M AlkhawajahSalman Aljarallah
May 18, 2021·International Journal of Epidemiology·Elisa BaldinMaura Pugliatti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Multiple Sclerosis : Clinical and Laboratory Research
Kjetil BjørnevikM Pugliatti
Multiple Sclerosis : Clinical and Laboratory Research
Kristin WesnesKjell-Morten Myhr
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Ersilia LucenteforteCarlo La Vecchia
© 2021 Meta ULC. All rights reserved